Digitisation | January 14, 2022
Hekka Labs introduces decentralized chronic disease data management in South Asia
Three Indian firms namely Curisin, Immunidex and Telemedicine Indian company are part of the first phase
Three Indian firms namely Curisin, Immunidex and Telemedicine Indian company are part of the first phase
The newly formed SAB will provide strategic direction across research, clinical development, and regulatory pathways
The programme has already drawn over 120 complex percutaneous coronary intervention (PCI) case submissions from across the country
Consensus calls for nationwide adoption of potassium-enriched salt to reduce cardiovascular disease risk
The aim is to bolster healthcare delivery in a region increasingly burdened by chronic disease
_256_384.jpg)
Effective recovery at home begins with well-defined care plans that outline treatment protocols, recovery milestones, and monitoring requirements tailored to individual patient needs
Each program will rely on partnerships between Novartis teams and local networks—including health authorities, community organizations and private sector groups
Novo Nordisk continues to position Wegovy as a cornerstone of its obesity treatment portfolio
The initiative is aimed at strengthening the district-level screening and chronic disease management infrastructure
In just the last few days, companies including Lupin, Biocon, Alembic Pharmaceuticals and Aurobindo Pharma have announced approvals for 5 mg and 10 mg tablets, all bioequivalent to Farxiga
Subscribe To Our Newsletter & Stay Updated
